364 results
Page 4 of 19
8-K
EX-99.1
dxzv1k5t6eh
4 Jan 21
Bristol Myers Squibb Provides Update on Status of Contingent Value Rights
8:00am
SC TO-T/A
EX-99
aq1j7c gl8pt
17 Nov 20
Third party tender offer statement (amended)
8:33am
8-K
EX-99.1
6z133xa8zclcl
13 Nov 20
Bristol Myers Squibb Prices $7 Billion of Senior Unsecured Notes
8:13am
8-K
EX-99.1
bk8fafgn9d
5 Nov 20
Bristol Myers Squibb Reports Third Quarter 2020 Financial Results
8:10am
SC TO-T/A
EX-99
nqhinf
4 Nov 20
Third party tender offer statement (amended)
7:01am
SC TO-T
EX-99
jx4fb1z2z8o2hxjlwk
19 Oct 20
Third party tender offer statement
6:03am
SC TO-C
EX-99.6
089wa1tor
5 Oct 20
Information about tender offer
5:13pm
SC TO-C
EX-99.1
hlenolzt
5 Oct 20
Information about tender offer
5:13pm
8-K
EX-99.1
mgj2ng
5 Oct 20
Bristol Myers Squibb to Acquire MyoKardia for $13.1 Billion in Cash
4:05pm
8-K
EX-99.1
6cv4peqlej
6 Aug 20
Bristol Myers Squibb Reports Second Quarter 2020 Financial Results
7:57am
8-K
EX-99.1
0o15ime9a2p
30 Jul 20
Bristol Myers Squibb Board Elects Two New Independent Directors
7:15am
8-K
EX-99.1
667i4o53 qd
16 Jul 20
Bristol Myers Squibb Announces Expiration and Final Results of Registered Exchange Offers
8:30am
8-K
EX-99.1
pmpib3dj7wntgzi
16 Jun 20
Bristol Myers Squibb Announces Commencement of Registered Exchange Offers
8:39am
8-K
EX-99.1
rg8ywj
7 May 20
Bristol Myers Squibb Reports Strong First Quarter 2020 Financial Results
8:08am
DEFA14A
2dwo25rv4nf62z0us ef
23 Apr 20
Additional proxy soliciting materials
8:59am
8-K
EX-99.1
pjgaxp
14 Apr 20
Bristol Myers Squibb Announces Virtual 2020 Annual Meeting of Shareholders
4:36pm